Valor preditivo de marcadores séricos de fibrose hepática em pacientes portadores de hepatite crônica viral C

• Autor(a) principal: Lima, Leila Maria Soares Tojal de Barros [UNIFESP]
• Data de Publicação: 2008
• Outros Autores: Martins, João Roberto Maciel [UNIFESP], Nader, Helena Bonciani [UNIFESP], Lacet, Celina Maria Costa, Balwani, Maria Do Carmo Lins Vasconcelos, Pinhal, Maria Aparecida da Silva [UNIFESP]
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1590/S1676-24442008000300005; http://repositorio.unifesp.br/handle/11600/4409
• topic: Serum markers; Hepatic fibrosis; Chronic hepatitis C; Hyaluronic acid; Marcadores séricos de fibrose hepática; Ácido hialurônico; Fibrose hepática; Hepatite crônica C

INTRODUCTION: Serum markers have been used in the assessment of liver fibrosis in patients with chronic hepatitis C (CHC). AIMS: We evaluated the capacity of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, gama-glutamyltransferase (GGT) levels, platelet count, the AST to platelet ratio index (APRI) and serum hyaluronic acid (HA) to predict the intensity of hepatic fibrosis in patients with CHC and the variation of these markers after therapy with interferon. PATIENTS AND METHODS: In 72 patients with hepatitis C, AST/ALT ratio, GGT levels, platelet count, the APRI index (calculated as the ratio of AST to platelets) and serum HA concentration were determined and compared to histological staging according to the scoring system of METAVIR. Sixty-five patients received interferon and ribavirin therapy. The individuals that completed the treatment (n = 33) underwent a new test for serum marker of fibrosis in order to compare it with pre-treatment levels. RESULTS: GGT levels, platelet count, the APRI index and serum HA were correlated with the stage of hepatic fibrosis (p < 0.01), except AST/ALT ratio. The analysis of the areas under the ROC curve (AUC) evidenced that APRI and HA levels were the markers with the best association with hepatic staging: AUC (APRI) = 0.85 and AUC (HA) = 0.86. After therapy with interferon, only GGT and the APRI showed reduction of their levels (p < 0.05). CONCLUSION: HA and the APRI index were the most accurate approaches to liver fibrosis staging and they may be used as alternative diagnostic methods in patients with CHC.